Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic womenOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This cross-sectional study examined how HPV, vaginal pH, vaginal microbiota, and local immune signals relate to the severity of cervical disease. Researchers wanted to know what beyond HPV infection contributes to cervical cancer. They genotyped HPV, measured vaginal pH, sequenced the vaginal microbiota using 16S ribosomal RNA (V4 region), and measured 22 immune mediators in cervicovaginal lavages. They also compared Hispanic and non-Hispanic women.
Who was studied?
The cohort was 100 premenopausal, non-pregnant women in Phoenix, Arizona. They fell into five groups: 20 HPV-negative controls, 31 HPV-positive controls, 12 low-grade dysplasia, 27 high-grade dysplasia, and 10 invasive cervical carcinoma. Forty-seven percent were Hispanic and 53 percent non-Hispanic. Women with recent antibiotics, current vaginal infection, or other listed conditions were excluded. Disease groups were set by biopsy histology or cytology.
What were the most important findings?
Abnormal vaginal pH (above 4.5) rose with disease severity, reaching 92.6 percent in high-grade dysplasia and 100 percent in invasive carcinoma. Hispanic women had more abnormal pH (89.1 versus 68.8 percent). Lactobacillus dominance fell and diverse anaerobes rose with severity; non-Lactobacillus-dominant microbiota increased in low-grade (67 percent), high-grade (56 percent), and invasive cancer (80 percent). Sneathia was enriched across HPV-positive and diseased groups. HPV16 and HPV31 were more common in Hispanic women. Only invasive carcinoma, not precancer, showed elevated genital inflammation and mediators such as TNF-alpha and IL-36-gamma. IL-36-gamma was tied to cancer regardless of microbiota.
What are the greatest implications of this study?
The study suggests the local microenvironment, not HPV alone, tracks with cervical cancer progression. Elevated vaginal pH and loss of protective lactobacilli may serve as accessible markers of advancing disease, and could help explain ethnic disparities in cervical cancer. IL-36-gamma stands out as a cancer-associated signal worth further study, though its role could be protective or harmful. Because the design is cross-sectional with only 10 cancer cases, it shows associations, not causation, and longitudinal studies are needed.